SAB Biotherapeutics ( (SABS)) has provided an update. On December 29, 2025, SAB Biotherapeutics, Inc. entered into a new sales agreement with UBS Securities LLC to establish an at-the-market equity ...
TORONTO--(BUSINESS WIRE)-- Cybin Inc. (CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to advancing mental healthcare by developing new and innovative ...
Quantum Biopharma ( (TSE:QNTM)) has issued an update. On December 22, 2025, Quantum BioPharma Ltd. announced that it had entered into an at-the-market offering agreement with Rodman & Renshaw LLC, ...
After market close on Tuesday, FuelCell said in a filing it entered into an amended sales agreement to increase the amount of shares that may be sold under its sales agreement to $200 million.
Nebius Group is well-positioned for strong 2026 performance, driven by large AI infrastructure contracts with Meta and Microsoft. NBIS demand remains robust, with all available capacity sold out in Q3 ...
On this blog, we have commented quite a number of times regarding a number of trends affecting our capital markets—many of which have been a factor since the early 2000s and which have become more ...
DURHAM, N.C.--(BUSINESS WIRE)--Wolfspeed, Inc. (NYSE: WOLF) announced today that it has completed the offering of shares of its common stock under its previously announced “at the market” offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback